Renal failure associated with a specific inhibitor of BCR-ABL tyrosine kinase, STI 571 [4]

Nephrology Dialysis Transplantation

Volumn 17, Issue 4, 2002, Pages 685-687

  Kitiyakara, Chagriya ^a   Atichartakarn, Vichai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; ANTIBIOTIC AGENT; BCR ABL PROTEIN; BUDESONIDE; CEFOPERAZONE; CYCLOSPORIN A; CYTARABINE; DIURETIC AGENT; FUROSEMIDE; GEMFIBROZIL; IMATINIB; IMIPENEM; NIFEDIPINE; PREDNISOLONE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; SIMVASTATIN; SULBACTAM; TERBUTALINE;

AGED; BLAST TRANSFORMATION; BODY WEIGHT; CASE REPORT; CHRONIC KIDNEY FAILURE; CHRONIC MYELOID LEUKEMIA; CONCENTRATION (PARAMETERS); DEATH; DOSE RESPONSE; DRUG SPECIFICITY; DRUG WITHDRAWAL; ECHOGRAPHY; HEMODIALYSIS; HOSPITALIZATION; HUMAN; HYDRATION; LETTER; MALE; PALLIATIVE THERAPY; PATHOGENESIS; PRIORITY JOURNAL; SIDE EFFECT; URINALYSIS; URINE VOLUME;

EID: 0036229691     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.4.685     Document Type: Letter

References (7)

1. Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia
2. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
3. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
4. High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency
5. Low-dose cytarabine-induced hepatic and renal dysfunction in a patient with myelodysplastic syndrome
6. Role of PDGF B-chain and PDGF receptors in rat tubular regeneration after acute injury
7. PDGF signal transduction inhibition ameliorates experimental mesangialproliferative glomerulonephritis